Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 17

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 17
---
4:

|                                                              |     | For the Six Months Ended 
 June 30,                 |       2025 |   |     |   |       2024 |   |
|:-------------------------------------------------------------|:----|:-------------------------|-----------:|:--|:----|:--|-----------:|:--|
| Net cash used in operating activities                        |     | $                        | (2,073,801 | ) |     | $ | (1,530,498 | ) |
| Net cash provided by financing activities                    |     |                          |  3,480,782 |   |     |   |  1,185,576 |   |
| Effect of exchange rate changes on cash and cash equivalents |     |                          |          — |   |     |   |          — |   |
| Net decrease in cash and cash equivalents                    |     | $                        |  1,406,981 |   |     | $ |   (344,922 | ) |

Operating Activities Net cash used in operating activities was $2,073,801 for the six months ended June 30, 2025, representing an increase of $543,303, or 35.5%, compared with net cash used in operating activities of $1,530,498 for the six months ended June 30, 2024. The change in cash used in operating activities for the six months ended June 30, 2025 was due to our reporting a net loss of $2,220,671 for the six months ended June 30, 2025, representing an increase of $184,837, or 9.1%, compared with a net loss of $2,035,834 for the same period in 2024, driven primarily by (i) a $129,267 reduction in research and development costs for the six months ended June 30, 2025, (ii) a $145,010 reduction in general and administrative expenses for the six months ended June 30, 2025 and (iii) a $420,289 increase in merger transaction costs for the six months ended June 30, 2025. Financing Activities Net cash provided by financing activities of $3,480,782, for the six months ended June 30, 2025, consisted of $3,300,000 of net proceeds from the issuance of common shares in private placement offerings and proceeds from exercise of common share warrants of $182,782. Net cash provided